# Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

> **NCT00698789** · PHASE2 · TERMINATED · sponsor: **Incyte Corporation** · enrollment: 48 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** INCB019602
- **DRUG:** INCB019602
- **DRUG:** INCB019602
- **DRUG:** INCB019602
- **DRUG:** INCB019602
- **DRUG:** Placebo
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00698789
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2009-02
- **Final completion:** 2009-06
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** Study ended after diabetes development plan review. .
- **Last updated:** 2012-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00698789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00698789, "Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00698789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*